Coherus BioSciences, Inc.·4

Mar 1, 8:22 PM ET

Wahlstrom Mats 4

4 · Coherus BioSciences, Inc. · Filed Mar 1, 2022

Insider Transaction Report

Form 4
Period: 2022-02-25
Transactions
  • Award

    Common Stock

    2022-02-25$11.64/sh+10,006$116,43310,006 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2022-02-28+29,9940 total
    Exercise: $2.08Exp: 2022-12-14Common Stock (29,994 underlying)
  • Award

    Common Stock

    2022-02-28$2.08/sh+29,994$62,50140,000 total
Footnotes (1)
  • [F1]The underlying shares subject to the option are fully vested and exercisable.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4